MREO — Mereo BioPharma Share News
0.000.00%
Last trade - 00:00- $44.96m
- $14.85m
- $0.50m
Brief: Mereo Biopharma Announces Appointment Of Anne Hyland To Board Of Directors
Brief: UAB And Mereo Biopharma Group Announce Positive Top-Line Results From “Costa” A Phase 1B/2 Trial Of Alvelestat (Mph966) In Hospitalized Patients With Covid-19 Respiratory Disease
Mereo BioPharma up on promising interim data from cancer study
Brief: Mereo Biopharma Reports Interim Data From Study Of Etigilimab Anti-Tigit Antibody In Combination With Nivolumab In Solid Tumors
Brief: Mereo Biopharma Says FDA Granted Orphan Drug Designation To Alvelestat For Treatment Of Alpha-1 Antitrypsin Deficiency
Brief: Mereo Biopharma Group PLC Files For Primary Offering Of Up To $250 Million Of Ordinary Shares - SEC Filing
Brief: Mereo Biopharma Announces Positive Desmosine Biomarker Data From An Interim Analysis Of An Investigator Initiated Study Of Alvelestat In Bronchiolitis Obliterans Syndrome (Bos)
Brief: Point72 Asset Management, L.P. Reports Passive Stake Of 6.4% In Mereo Biopharma Group PLC
Brief: Mereo Biopharma Prices Underwritten Public Offering Of 34.5 Million ADSS At $2.90 Per ADS
Brief: Mereo Biopharma Group PLC Announces Proposed Public Offering Of American Depositary Shares
Brief: Mereo Biopharma Group Files For Offering Of Up To 103.1 Million Adss By The Selling Shareholders
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:51 AM
Brief: Mereo Biopharma Group Files Prospectus Relates To Sale Of Up To $28.3 Mln Or 17.9 Mln Adss By Aspire Capital Fund
Mereo BioPharma: Jumps on financing deals with Novartis, Aspire Capital
U.S. STOCKS ON THE MOVE-JPMorgan Chase, Wells Fargo, GameStop, Tesla, Boston Scientific
U.S. STOCKS ON THE MOVE-JPMorgan Chase, Tesla, GameStop Corp, Aphria, Freeport-McMoRan
Mereo BioPharma: Surges on more positive trial data for bone disorder drug
U.S. STOCKS ON THE MOVE-Tesla, Abiomed, Adaptimmune Therapeutics
Mereo BioPharma: Rises on licensing agreement for its ovarian cancer drug